These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12052197)

  • 1. 5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.
    López-Rodriguez ML; Benhamú B; Morcillo MJ; Murcia M; Viso A; Campillo M; Pardob L
    Curr Top Med Chem; 2002 Jun; 2(6):625-41. PubMed ID: 12052197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-D-QSAR/CoMFA and recognition models of benzimidazole derivatives at the 5-HT(4) receptor.
    López-Rodríguez ML; Murcia M; Benhamú B; Viso A; Campillo M; Pardo L
    Bioorg Med Chem Lett; 2001 Nov; 11(21):2807-11. PubMed ID: 11597405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
    Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzimidazole derivatives. 3. 3D-QSAR/CoMFA model and computational simulation for the recognition of 5-HT(4) receptor antagonists.
    López-Rodríguez ML; Murcia M; Benhamú B; Viso A; Campillo M; Pardo L
    J Med Chem; 2002 Oct; 45(22):4806-15. PubMed ID: 12383006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT4 receptor ligands: applications and new prospects.
    Langlois M; Fischmeister R
    J Med Chem; 2003 Jan; 46(3):319-44. PubMed ID: 12540230
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285.
    Dumuis A; Gozlan H; Sebben M; Ansanay H; Rizzi CA; Turconi M; Monferini E; Giraldo E; Schiantarelli P; Ladinsky H
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):264-9. PubMed ID: 1320204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.
    Westkaemper RB; Glennon RA
    Curr Top Med Chem; 2002 Jun; 2(6):575-98. PubMed ID: 12052195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzimidazole derivatives. Part 1: Synthesis and structure-activity relationships of new benzimidazole-4-carboxamides and carboxylates as potent and selective 5-HT4 receptor antagonists.
    López-Rodríguez ML; Benhamú B; Viso A; Morcillo MJ; Murcia M; Orensanz L; Alfaro MJ; Martín MI
    Bioorg Med Chem; 1999 Nov; 7(11):2271-81. PubMed ID: 10632037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation.
    de la Fuente T; Martín-Fontecha M; Sallander J; Benhamú B; Campillo M; Medina RA; Pellissier LP; Claeysen S; Dumuis A; Pardo L; López-Rodríguez ML
    J Med Chem; 2010 Feb; 53(3):1357-69. PubMed ID: 20078106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Interactions of the 5-HT(3) receptor with arylpiperazine, tropane, and quinuclidine ligands.
    Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Hamon M; De Benedetti PG; Menziani MC
    Curr Top Med Chem; 2002 Jun; 2(6):599-624. PubMed ID: 12052196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a series of 5-HT4 receptor agonists and antagonists on steroid secretion by the adrenal gland in vitro.
    Contesse V; Hamel C; Delarue C; Lefebvre H; Vaudry H
    Eur J Pharmacol; 1994 Nov; 265(1-2):27-33. PubMed ID: 7883026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.
    Bernotas RC; Antane S; Shenoy R; Le VD; Chen P; Harrison BL; Robichaud AJ; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1657-60. PubMed ID: 20138763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain.
    Dumuis A; Sebben M; Monferini E; Nicola M; Turconi M; Ladinsky H; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):245-51. PubMed ID: 1650917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
    Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.
    Parihar HS; Suryanarayanan A; Ma C; Joshi P; Venkataraman P; Schulte MK; Kirschbaum KS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2133-6. PubMed ID: 11514154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.
    Candura SM; Messori E; Franceschetti GP; D'Agostino G; Vicini D; Tagliani M; Tonini M
    Br J Pharmacol; 1996 Aug; 118(8):1965-70. PubMed ID: 8864530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzimidazole derivatives. 4. The recognition of the voluminous substituent attached to the basic amino group of 5-HT4 receptor antagonists.
    López-Rodríguez ML; Benhamú B; Murcia M; Alvaro E; Campillo M; Pardo L
    J Comput Aided Mol Des; 2003 Aug; 17(8):515-24. PubMed ID: 14703122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
    Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.
    Dumuis A; Sebben M; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):403-10. PubMed ID: 2555720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.